Search

everythinglearnresearchcommunity

for

Search:↓

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Hydroxychloroquine may help treat alopecia areata in children.

The review says skin conditions with sterile pustules need more research for better treatments.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Adalimumab helped control a child's severe eye disease when other treatments failed.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Some cancer treatments can cause permanent hair loss.

Minoxidil slows down keratinocyte growth without being toxic.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.